Search Results - "Taalab, Mona M"

Refine Results
  1. 1

    Prognostic Significance of Secreted Frizzled-Related Protein 2 Expression in Cytogenetically Normal Primary Acute Myeloid Leukemia by Aly, Rabab M., PhD, Taalab, Mona M., PhD, Abdsalam, Eman M., PhD

    “…Background Deregulation of secreted frizzled-related protein 2 (sFRP2) has been found in many types of cancer. However, the pattern of sFRP2 expression in…”
    Get full text
    Journal Article
  2. 2

    DNMT3A R882 mutations in patients with cytogenetically normal acute myeloid leukemia and myelodysplastic syndrome by El Ghannam, Doaa, Taalab, Mona M., Ghazy, Hayam F., Eneen, Asmaa F.

    Published in Blood cells, molecules, & diseases (01-06-2014)
    “…Several molecular markers have been described that help to classify patients with acute myeloid leukemia (AML), a heterogeneous hematopoietic tissue neoplasm,…”
    Get full text
    Journal Article
  3. 3

    Influence of interleukin-15 polymorphism on the survival of adult patients with acute lymphoblastic leukemia in Egypt by Aly, Rabab M., Taalab, Mona M., Ghazy, Hayam F.

    Published in Leukemia & lymphoma (01-01-2015)
    “…Abstract The aim of this study was to analyze the association of the rs10519612 and rs17007695 polymorphisms with the risk of acute lymphoblastic leukemia…”
    Get full text
    Journal Article
  4. 4

    MTHFR A1298C and C677T gene polymorphisms and susceptibility to chronic myeloid leukemia in Egypt by Aly, Rabab M, Taalab, Mona M, Ghazy, Hayam F

    “…Methylenetetrahydrofolate reductase (MTHFR) is a key enzyme regulating the intracellular folate metabolism which plays an important role in carcinogenesis…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7

    Prognostic implications of NPM1 mutations and FLT3 internal tandem duplications in Egyptian patients with cytogenetically normal acute myeloid leukemia by Shamaa, Sameh, Laimon, Nabil, Aladle, Doaa A, Azmy, Emad, Elghannam, Doaa M, Salem, Dalia A, Taalab, Mona M

    Published in Hematology (Luxembourg) (01-01-2014)
    “…Nucleophosmin (NPM1) and fms-like tyrosine kinase 3-internal tandem duplication (FLT3-ITD) gene mutations represent the most frequent molecular aberrations in…”
    Get more information
    Journal Article
  8. 8

    High expression of LMO2 predicts a favorable outcome in adult patients with BCR/ABL negative B-cell acute lymphoblastic leukemia by ALY, RABAB M, TAALAB, MONA M, ABDSALAM, EMAN M, ELYAMANY, OMAR H, HASAN, OMAR E

    Published in Oncology letters (01-03-2016)
    “…The LIM domain only protein 2 (LMO2) is a key regulator of hematopoietic stem cell development. Expression of LMO2 has been evaluated in B-cell lymphoma,…”
    Get full text
    Journal Article
  9. 9

    Prevalence and Prognostic Impact of CEBPA Gene Mutation (Simplified Assay Technique) in Egyptian Acute Myeloid Leukemia Patients with Normal Cytogenetics by Said, Samy B., El-Masry, Samir A., Salem, Dalia A., Taalab, Mona M., Al-posttany, Amr S.

    “…Mutations of the CCAAT /enhancer binding protein alpha ( CEBPA ) gene have been associated with a favorable outcome in patients with acute myeloid leukemia…”
    Get full text
    Journal Article
  10. 10
  11. 11

    IBCL-080 Single Egyptian Oncology Center Experience in Lymphoplasmacytic Lymphoma (LPL) by Shaaban, Yasmine, Taalab, Mona M.

    Published in Clinical lymphoma, myeloma and leukemia (01-09-2024)
    “…Lymphoplasmacytic lymphoma (LPL), or Waldenström macroglobulinemia (WM), is a B-cell disorder characterized primarily by bone marrow infiltration with…”
    Get full text
    Journal Article
  12. 12

    AML-002 The Effect of Elevated Serum Lactate Dehydrogenase Level on Survival of Newly Diagnosed Acute Myeloid Leukemia (AML) Patients by Shaaban, Yasmine, Taalab, Mona M.

    Published in Clinical lymphoma, myeloma and leukemia (01-09-2023)
    “…AML is a heterogeneous clonal neoplasm. The most common prognostic risk factors for AML are cytogenetic abnormalities and environmental risk factors…”
    Get full text
    Journal Article
  13. 13
  14. 14

    AML-029: The Prognostic Significance of Serum Lactate Dehydrogenase Level in Egyptian AML Patients by Shaaban, Yasmine, Taalab, Mona M., Aref, Salah, Mabed, Mohamed

    Published in Clinical lymphoma, myeloma and leukemia (01-09-2020)
    “…Acute myeloid leukemia (AML) is a clonal heterogeneous disorder. Poor-risk cytogenetics, and older age have been considered adverse risk factors for AML…”
    Get full text
    Journal Article
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20